Your search for "treatment" matched 175 page(s).
Showing results 1 to 10.
 New treatments for type 2 diabetes
					 - Volume 21, Issue
				New treatments for type 2 diabetes
					 - Volume 21, Issue 
			
		Type 2 diabetes (T2D) has become a burden for society, and the incidence of the disease continues to increase. A range of therapies is available to control glycaemia in T2D patients; however, these drugs have undesired side-effects and there is a…
 Developing a treatment for ovarian cancer
					 - Volume 21, Issue
				Developing a treatment for ovarian cancer
					 - Volume 21, Issue 
			
		Ovarian cancer is a really nasty disease. Although, like most cancers, it is curable if caught early enough, in practice it is not usually diagnosed until it is too late for curative treatment. It initially responds well to treatment and patients…
 RCTs: Can the treatment work? Patient registries: Does the treatment work?
					 - Volume 26, Issue
				RCTs: Can the treatment work? Patient registries: Does the treatment work?
					 - Volume 26, Issue 
			
		The first part of this article compares the main features of studies based on patient registry data with those of randomised clinical trials, providing a basis for better understanding the differences between the two. The second part details how to…
 The importance of Health Research in Horizon 2020: Diabetes as a model of a chronic disease and the need for sustainable funding
					 - Volume 21, Issue
				The importance of Health Research in Horizon 2020: Diabetes as a model of a chronic disease and the need for sustainable funding
					 - Volume 21, Issue 
			
		Diabetes is one of the most common chronic diseases and is estimated to affect more than 32 million European Union (EU) citizens, which is nearly 10% of the total EU population. An additional 32 million EU citizens are not yet diagnosed or have…
 Medical writing for cancer trials and submissions
					 - Volume 21, Issue
				Medical writing for cancer trials and submissions
					 - Volume 21, Issue 
			
		Cancer is currently a high-priority area for drug development. Most cancers are immediately life-threatening diseases demanding urgent treatment and therapies are usually highly toxic. This poses a range of specific challenges for the ethical…
 Providing value for medicines in older people
					 - Volume 22, Issue
				Providing value for medicines in older people
					 - Volume 22, Issue 
			
		The global population is ageing, but inequalities remain in older people's access to treatment, especially people 75 years of age and older. These people receive less frequent interventions and lower quality medical treatment than their younger…
 Living medicine: The story of CAR T cell therapy
					 - Volume 32, Issue
				Living medicine: The story of CAR T cell therapy
					 - Volume 32, Issue 
			
		The advent of chimeric antigen receptor (CAR) T cell therapies follows a decades-long quest to personalise the treatment of disease. This article highlights the early research that paved the way for the field today, touching on early pioneers in the…
 The Webscout
					 - Volume 21, Issue
				The Webscout
					 - Volume 21, Issue 
			
		Diabetes and Psychology You all may know that diabetes is a metabolic disease leading to secondary micro- and macrovascular complications, like nephropathy, neuropathy, and cardiovascular diseases. You may also know that these microvascular…
 Measuring health outcomes: The foundation of contemporary healthcare decision-making
					 - Volume 27, Issue
				Measuring health outcomes: The foundation of contemporary healthcare decision-making
					 - Volume 27, Issue 
			
		Healthcare professionals and patients are (or should be) interested in understanding the benefits of health care. We should be able to know the expected treatment benefits and to see quantifiable evidence that supports those expectations. Such…
 Scientific advice procedures in the EU – an overview ofthe regulatory background
					 - Volume 29, Issue
				Scientific advice procedures in the EU – an overview ofthe regulatory background
					 - Volume 29, Issue 
			
		The prerequisite for obtaining marketing authorisation is an appropriate and robust data package that demonstrates a medicinal product’s quality and its efficacy and safety in the proposed indication. Pharmaceutical companies can face regulatory…
Medical Writing is a quarterly publication that aims to educate and inform medical writers in Europe and beyond. Each issue focuses on a specific theme, and all issues include feature articles and regular columns on topics relevant to the practice of medical writing. We welcome articles providing practical advice to medical writers; guidelines and reviews/summaries/updates of guidelines published elsewhere; original research; opinion pieces; interviews; and review articles.
Medical Writing is listed in the following indexes:
Editor-in-Chief
Co-Editors
Senior Editor
Victoria White
Managing Editor
Alicia Brooks Waltman
Associate Editors
Section Editors
AI/Automation
Biotechnology
Digital Communication
EMWA News
Freelancing
Gained in Translation
Getting Your Foot in the Door
Good Writing Practice
Pablo Izquierdo / Alison McIntosh
In the Bookstores
Publications
Medical Communications/Writing for Patients
Medical Devices
My First Medical Writing
News from the EMA
Pharmacovigilance
Regulatory Matters
Regulatory Public Disclosure
Louisa Ludwig-Begall / Sarah Kabani
The Crofter: Sustainable Communications
Veterinary Writing
Editors Emeritus
Layout Designer
Chris Monk